PDIA3 and cancer: Furthermore, studies have shown that diethylstilbestrol, an endocrine disruptor, was once used to treat gynecological problems, but it was later confirmed to be carcinogenic (55); this might be explained by the results of diethylstilbestrol activating PDIA3, which is a poor prognostic factor of many cancers.